You just read:

Novartis Pharmaceuticals Canada Inc. announces results at 2014 ATS International Conference for once daily dual bronchodilator Ultibro® Breezhaler® versus combination therapy for COPD

News provided by

Novartis Pharmaceuticals Canada Inc.

May 21, 2014, 08:00 ET